SAN ANTONIO, TX / ACCESSWIRE / July 22, 2014 / Professional golfer Tom Proben has been named both Official Spokesperson and Equity partner of “Type2 DefenseTM,” a product owned by Bio‑Solutions Corporation (OTCQB:BISU).
“I’m thrilled to be a part of the Bio-Solutions family and to be representing Type2 DefenseTM, which has significant health benefits for Type-2 diabetes sufferers. I look forward to utilizing my golf platform to educate people about this revolutionary product.
Type2 DefenseTM was developed by Dr. Chandraskehar Mallangi, a former Nestlé USA nutritional Innovator and Developer of multiple Nestlé USA Product lines. The product is a nutritional supplement delivered as a soluble that targets health conscious individuals diagnosed as Type II diabetics, as well as individuals taking a proactive approach to pre‑diabetic symptoms. The Type2 DefenseTM power blend is a safe and all-natural supplement that can aid the stabilization of healthy glucose levels and healthy blood pressure through a compound that includes strong antioxidants. The mix contains green tea, cinnamon and blueberry flavors, and the Type2 DefenseTM proprietary blend.
“We are so pleased to have Tom helping us spread awareness of our product,” stated Chairman of the Board, James Hodge. “Tom’s ability to provide education regarding Type2 Defense™ as well as exposure for the product provides a winning combination for Bio-Solutions Corporation.”
A graduate of Eastern Michigan University, Mr. Proben obtained a Bachelor of Science in Mathematics degree with a minor in Physics. While at EMU, he served as Captain of the golf team and was twice named Mid-American Conference Long Drive Champion. Outside of golf, Mr. Proben has been employed as a field civil engineer for Disney, Universal Studios, Florida Hospital, & Morton Plant in Clearwater Beach, FL. He was also President of H2O Depot, water treatment in three locations, Orlando, DeBary, & St. Augustine, FL., and worked on a $400M project for the State of Florida. Proben is the 2010 RE/Max Long Drive Grand Champion, and competes in numerous professional golf tournaments around the country, dividing his time between Detroit, MI and Southwest Florida.
About Bio-Solutions Corp.
Bio-Solutions Corp (OTCQB:BISU), Owns and Markets Type2 DefenseTM, a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. The company believes that there is a growing Diabetic target market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense is a powder blend of natural ingredients that has been developed to maintain healthy blood glucose levels. For more information, visit http://biosolutiosncorp.com/, or http://type2defense.com/.
Courtesy of Annex Communication. Contact: Kelly Coughlin, (954) 332-3688 – Office; (954) 294‑9135 – Cell; email is: [email protected].
NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.” Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management’s views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
Source: Bio-Solutions Corp.